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Regulating assisted reproductive technologies in Victoria: 
The impact of changing policy concerning the accessibility of 
in vitro fertilisation for preimplantation tissue-typing 
Malcolm K Smith 
On 1 January 2010, the Assisted Reproductive Treatment Act 2008 (Vic) came into force. The 
legislation was the outcome of a detailed review and consultation process undertaken by the 
Victorian Law Reform Commission. Arguably, the change to the regulatory framework 
represents a significant shift in policy compared to previous regulatory approaches on this 
topic in Victoria. This article considers the impact of the new legislation on eligibility for 
reproductive treatments, focusing on the accessibility of such services for the purpose of 
creating a “saviour sibling”. It also highlights the impact of the Victorian regulatory body’s 
decision to abolish its regulatory policies on preimplantation genetic diagnosis and 
preimplantation tissue-typing, concluding that the regulatory approach in relation to these 
latter issues is similar to other Australian jurisdictions where such practices are not addressed 
by a statutory framework. 
INTRODUCTION 
Victoria was the first common law jurisdiction in the world to enact legislation to regulate assisted 
reproductive technologies (ARTs).
1
 Since the Infertility (Medical Procedures) Act 1984 (Vic) was passed, the 
legislative framework in Victoria has been updated a number of times in response to scientific and medical 
advances, and also evolving social attitudes.
2
 The enactment of the most recent legislation, the Assisted 
Reproductive Treatment Act 2008 (Vic), has resulted in some of the most significant changes to the Victorian 
statutory framework since it was first established. These changes have been implemented as a result of the 
extensive review of the law conducted by the Victorian Law Reform Commission (VLRC)
3
 and the new 
legislative scheme came in to effect on 1 January 2010. 
Other commentators have also recently considered how the changes to the Victorian framework have 
impacted on the provision of ART services in Victoria.
4
 Although this article similarly considers the accessibility 
of in vitro fertilisation (IVF) services following the changes to the statutory scheme, it pays particular attention 
to the accessibility of such services for families who wish to utilise embryo selection techniques in order to 
establish the tissue-type (also referred to as human leukocyte antigen) of an embryo before implantation. 
Focusing the discussion in this way also allows a consideration of another significant change in Victorian policy 
which came into effect recently concerning the regulation of preimplantation genetic diagnosis (PGD). The 
reason for this focus should become clear as the discussion progresses, but in summary, it is warranted on the 
basis of the impact that the changes to the regulatory framework in Victoria have had. Prior to considering this 
particular issue, this article provides an overview of the changes to the Victorian ART regulatory framework 
within the context of the national framework of professional guidelines that are currently in place. 
Before progressing to the main discussion, it is also worth summarising the practical aspects of the 
technology that is utilised for the purposes of screening embryos during the IVF process. PGD is a technique 
that was originally developed to establish which, out of a number of embryos created in the IVF cycle, contain 
the genetic identifiers for certain hereditary conditions or disorders.
5
 This enables an embryo to be implanted 
in the knowledge that any child born following the technology will be free from the particular genetic 
condition which her or his parents were at risk of transmitting via natural conception. PGD has advanced 
significantly since it was first developed and the underlying purpose of the technology’s application has also 
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begun to change. In addition to being used as a means to test for and prevent transmission of specific genetic 
conditions, PGD has also been used to positively identify characteristics that are desired within future 
offspring. One example is where the technique is used to identify and implant embryo(s)
6
 which are of a 
matching tissue-type to an existing child (normally a sibling of the child who may result from the IVF process). 
Any child born following this specific use of PGD may potentially benefit an existing sibling who is suffering 
from a condition that is potentially curable (or at least treatable) with a transplant of blood stem cells, blood 
products, or bone marrow (referred to as hematopoietic stem cell transplantation procedures). The success of 
the procedure is dependent upon the tissue compatibility of the donor and recipient.
7
 The success rate of an 
hematopoietic stem cell transplantation procedure is far higher for human leukocyte antigen-identical sibling 
donations,
8
 which is why some families elect to conceive a further child who can act as a sibling donor.
9
 
Families seeking access to preimplantation tissue-typing in Australia are, as a minimum, expected to 
justify their motives to a clinical ethics committee before access to the technology will be granted. As 
discussed below, prior to the recent regulatory reforms in Victoria, the accessibility of preimplantation tissue-
typing was further restricted. Although the recent changes to the Victorian legislation potentially lessen the 
restrictive nature of the regulatory approach, the result is that some families may be required to have their 
reproductive decisions subject to the scrutiny of multiple committees before they are able to access tissue-
typing techniques. This article argues that there is a need to reconsider this approach. 
 
THE REGULATION OF ASSISTED REPRODUCTIVE TECHNOLOGIES IN AUSTRALIA 
In short, there is no single regulatory approach in Australia to address the issues raised by ART practices at a 
national level.
10
 However, there is Commonwealth legislation addressing human embryo research and cloning 
which is of some relevance.
11
 The Commonwealth legislation overseeing human embryo research imposes 
criminal sanctions on ART clinics for providing any reproductive treatments involving human embryos without 
accreditation from the Reproductive Technology Accreditation Committee (RTAC) which is overseen by the 
Fertility Society of Australia (FSA).
12
 The terms of the accreditation process require clinics to adhere to all 
relevant legislation and applicable guidelines and the RTAC Code of Practice
13
 requires adherence to the 
                                                          
6 The preimplantation genetic diagnosis process used to establish the tissue-type of a couple’s embryos is not, strictly speaking, a 
“diagnosis” of the embryo’s genetics. However, the term “preimplantation genetic diagnosis” can be used as an umbrella term which 
encompasses embryo testing techniques such as preimplantation tissue-typing. Thus, the term is used to encompass wider uses of the 
technology and the physical process involved in the biopsy procedure is the same regardless of whether the purpose is to detect a genetic 
condition or to establish tissue-type. 
7 Anasetti C, “What are the Most Important Donor and Recipient Factors Affecting the Outcome of Related and Unrelated Allogeneic 
Transplantation?” (2008) 21(4) Best Practice & Research Clinical Haematology 694. 
8 Anasetti, n 7 at 694-695. 
9 There is some literature which considers whether the option of using IVF for human leukocyte antigen typing should be considered and 
discussed with the family by the paediatrician (or paediatric team) treating the existing sick child. For a discussion of these issues see 
Samuel GN, Strong KA, Kerridge I, Jordens CFC, Ankeny RA and Shaw PJ, “Establishing the Role of Pre-implantation Genetic Diagnosis with 
Human Leucocyte Antigen Typing: What Place Do ‘Saviour Siblings’ Have in Paediatric Transplantation?” (2009) 94 Arch Dis Child 317; 
Strong KA, “Informing Patients about Emerging Treatment Options: Creating ‘Saviour Siblings’ for Haemopoietic Stem Cell Transplant” 
(2009) 190 MJA 506. 
10 There have been a number of recommendations arguing in favour of a national approach for regulating assisted reproductive 
technology in Australia. The Family Law Council of Australia report recommended that a multidisciplinary body oversee matters relating to 
reproductive technology at a national level: Family Law Council of Australia, Creating Children: A Uniform Approach to the Law and 
Practice of Reproductive Technology in Australia (AGPS, 1985). The functions of the body were suggested to include advising federal and 
State governments; monitoring medical research; analysing the implications of assisted reproductive technology for society; providing 
information for the community; developing clear guidelines for ethics, practice records, access to information and counselling; 
recommending research on the ongoing effects of reproductive technology; and presenting an annual report. The plans to establish such a 
body were not followed through fully, but the National Bioethics Consultative Committee (NBCC) was created, which, according to 
Chalmers, had success in focusing debate and preparing reports, but not in changing public policy. For a detailed review of the 
development of such issues, see Chalmers D, “Professional Self-regulation and Guidelines in Assisted Reproduction” (2002) 9 JLM 414.  
11 Prohibition of Human Cloning Act 2002 (Cth); Research Involving Human Embryos Act 2002 (Cth). Both Acts were reviewed by a 
Legislation Review Committee in 2005 (Australian Government, Legislation Review: Prohibition of Human Cloning Act 2002 and the 
Research Involving Human Embryos Act 2002 (2005) (the Lockhart Review)) and subsequently reformed: see Prohibition of Human Cloning 
for Reproduction and the Regulation of Human Embryo Research Amendment Act 2006 (Cth). For an overview of the issues arising from 
the Review, see Cooper D, “The Lockhart Review: Where Now for Australia?” (2006) 14 JLM 27. 
12 The FSA considers the meaning of s 11 of the Research Involving Human Embryos Act 2002 (Cth) to encompass the use of human 
embryos in any way without RTAC accreditation to amount to a criminal offence under Commonwealth law: Fertility Society of Australia, 
Reproductive Technology Accreditation Committee, Code of Practice for Assisted Reproductive Technology Units (revised October 2010). 
That section states that a person who “intentionally uses, outside the body of a woman, a human embryo that is not an excess ART 
embryo; and the use is not for a purpose relating to the assisted reproductive technology treatment of a woman carried out by an 
accredited ART centre”, commits an offence. Section 8 of the Research Involving Human Embryos Act 2002 (Cth) defines an “accredited 
ART centre” as a “person or body accredited to carry out assisted reproductive technology by the Reproductive Technology Accreditation 
Committee of the Fertility Society of Australia”. 
13 Fertility Society of Australia, Reproductive Technology Accreditation Committee, n 12. 
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National Health and Medical Research Council (NHMRC) Guidelines.
14
 Until recently, many Australian States 
and Territories have relied on this form of regulation alone. Only four States have passed legislation to address 
the broader issues associated with ARTs,
15
 with the Victorian model being the first and most comprehensive 
regulatory framework in place in Australia.
16
 
As outlined above, there are various guidelines that must be adhered to as a condition of RTAC 
accreditation. The first mentioned is the RTAC Code of Practice, which establishes national standards that 
apply to all ART providers.
17
 The RTAC Code of Practice mainly addresses aspects of clinical practice. The code 
also overlaps with some other regulatory aspects relevant to the provision of ART services and addresses 
issues relating to consent, storage of gametes and embryos, and counselling.   
The second relevant set of guidelines is the NHMRC’s Ethical Guidelines on Assisted Reproductive 
Technology. The NHMRC Guidelines aim to address a number of social and ethical concerns relating to ART 
practices and have been described by some commentators as national standards of acceptable practice.
18
 The 
provisions address, among other things: 
 the use and storage of gametes and embryos (including donated gametes and embryos);
19
 
 the level of information that clinics must give to those seeking treatments;
20
 
 the counselling and consent requirements for participants undergoing treatments;
21
  
 the requirement for the keeping of records and data by clinics;
22
 and 
 preimplantation genetic diagnosis, sex selection and surrogacy.
23
 
When the NHMRC Guidelines were first issued in 1996, the more controversial aspects of ART practice (such as 
sex selection, PGD and surrogacy) were not addressed by the Guidelines, as they were considered to be 
beyond the remit of the Australian Health Ethics Committee (AHEC), the major committee of the NHMRC 
responsible for developing the Guidelines.
24
 However, the NHMRC issued a call to all States and Territories to 
adopt a uniform and comprehensive framework of legislation so that the social and ethical issues concerning 
the more controversial aspects of ART were addressed. The most recent edition of the Guidelines has 
responded to many of these issues due to the lack of legislative action within many Australian States and 
Territories.
25
 Victoria has regulated the field of ARTs comprehensively and is one of the few jurisdictions to 




THE REGULATION OF ASSISTED REPRODUCTIVE TECHNOLOGIES IN VICTORIA 
The Assisted Reproductive Treatment Act 2008 (Vic) has repealed the provisions of the former Infertility 
Treatment Act 1995 (Vic).
27
 Fundamentally, the change in the Victorian legislation is representative of the 
change in the underlying philosophy of the regulatory approach to ART services in Victoria. Thus, one Member 
of Parliament noted that the new statutory framework represents “a change in focus from treatment of 
                                                          
14 National Health and Medical Research Council, Ethical Guidelines on the Use of Assisted Reproductive Technology in Clinical Practice and 
Research (2007) (NHMRC Guidelines). 
15 Assisted Reproductive Treatment Act 2008 (Vic); Reproductive Technology Act 1991 (WA); Assisted Reproductive Treatment Act 1988 
(SA); Assisted Reproductive Technology Act 2007 (NSW). 
16 See Szoke H, “Regulation of Assisted Reproductive Technology: The State of Play in Australia” in Freckelton I and Petersen K (eds), 
Controversies in Health Law (Federation Press, Sydney, 1999). 
17 Fertility Society of Australia, Reproductive Technology Accreditation Committee, n 12. 
18 Chalmers, n 10 at 418. 
19 NHMRC Guidelines, n 14 at [6], [7] and [8]. 
20 NHMRC Guidelines, n 14 at [9]. 
21 NHMRC Guidelines, n 14 at [9]. 
22 NHMRC Guidelines, n 14 at [10]. 
23 NHMRC Guidelines, n 14 at [11]-[13]. 
24 See NHMRC, Ethical Guidelines on Assisted Reproductive Technology (1996) p v. 
25 See Szoke H, Neame L and Johnson L, “Old Technologies and New Challenges: Assisted Reproduction and Its Regulation” in Freckelton I 
and Petersen K, Disputes and Dilemmas in Health Law (Federation Press, Sydney, 2006) p 197. 
26 Some have argued that the Victorian framework is, in fact, too prescriptive and that this results in an inability to keep up with the 
technological and social developments in this field of practice. See Petersen K, “The Regulation of Assisted Reproductive Technology: A 
Comparative Study of Permissive and Prescriptive Laws and Policies” (2002) 9 JLM 483. 
27 Assisted Reproductive Treatment Act 2008 (Vic), s 1(g). 
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infertility to a broader purpose of regulating assisted human fertilisation procedures”.
28
 This is immediately 
obvious from the change in the title of the Act.
29
 
Some of the former legislative provisions are changed significantly by the new Act. A new statutory 
body replaces the Infertility Treatment Authority (ITA) and the creation of a separate review panel has been 
implemented to consider applications by prospective participants who do not meet the statutory eligibility 
criteria.
30
 The legislation widens the restrictive eligibility criteria previously in force in Victoria (discussed 
below). It also seeks to further entrench the rights of donor-conceived children to access information about 
their genetic origins, and implements detailed provisions relating to the practice of surrogacy.
31
  
Under the former 1995 legislation, the ITA was created as an independent statutory body responsible 
for regulating the provision of ART services in Victoria.
32
 To replace the ITA, the 2008 legislation establishes the 
Victorian Assisted Reproductive Treatment Authority (VARTA).
33
 Some of the duties and responsibilities 
previously undertaken by the ITA
34
 have not transferred to the new body.
35
 However, the VARTA is responsible 
for: 
 administration of the system of registration for ART providers; 
 undertaking public education about treatment procedures and the best interests of children born as a 
result of treatment procedures; 
 consulting with the community about matters relevant to the legislation; 
 monitoring the programs and activities in relation to the Act, programs and activities relating to the 
causes and prevention of infertility, and programs and activities relating to treatment outside 
Victoria; 
 keeping the body’s functions, operation and composition under review; 
 promoting research into the causes and prevention of infertility; 
 approving the import and export of gametes and embryos; and 
 other functions required by the Act or any other Act.
36
 
The legislative scheme (and its administration) is informed by the five guiding principles contained 
within the legislation: 
 the welfare and interests of persons born or to be born as a result of treatment procedures are to be 
paramount; 
 at no time should the use of treatment procedures be for the purposes of exploiting the reproductive 
capabilities of men and women, or children born as a result of treatment procedures; 
 children born as a result of the use of donated gametes have a right to information about their 
genetic origins; 
 the health and wellbeing of persons undergoing treatment procedures must be protected at all times; 
and 
                                                          
28 Victoria, Legislative Assembly, Parliamentary Debates (10 September 2008) p 3442 (Rob Hulls). Another Member of Parliament noted 
that the “Bill abandons the long-held principle of Victorian legislation that reproductive treatment is to help infertile couples to have 
children and replaces it with the concept that any person who is unable or unwilling to have children by natural means can have children 
produced for them”: Victoria, Legislative Assembly, Parliamentary Debates (7 October 2008) p 3759 (Robert William Clark). 
29 Thus, as one Member acknowledged when the Bill was passing through the Legislative Assembly, “[t]he change is explicit even in the 
name of the Bill”: Victoria, Legislative Assembly, Parliamentary Debates (7 October 2008) p 3783 (David Morris). 
30 The Patient Review Panel will also have responsibility for approving certain uses of assisted reproductive technology, such as surrogacy 
and posthumous conception, and extending permitted storage periods of gametes and embryos under the legislation: Assisted 
Reproductive Treatment Act 2008 (Vic), s 85. 
31 See eg Assisted Reproductive Treatment Act 2008 (Vic), Pts 4 and 6. 
32 Infertility Treatment Act 1995 (Vic), s 121. The ITA proclaimed that since its formation in 1996 it had sought to ensure that those seeking 
treatment receive appropriate information and counselling; that it assisted in the smooth provision of health care by treatment 
institutions; that it gathered and stored information relevant to the proper regulation and broad oversight of the provision of reproductive 
assistance and released such where appropriate; and that it promoted a community understanding of the complex issues involved in 
fertility treatments and reported to Parliament under the terms of the Act: Infertility Treatment Authority, Annual Report (2006) p 8. 
33 Assisted Reproductive Treatment Act 2008 (Vic), s 99. 
34 This includes the requirement to compile and provide access to records relating to treatment procedures, including access to records of 
donors of gametes and children born as a result of treatment procedures by those seeking identifying information. The ITA also had the 
responsibility of issuing licences for treatment services and research. This involved issuing a licence to a treatment centre so that research 
could be carried out at a centre, and approving medical professionals and scientists who were involved in the delivery of such services. The 
ITA was also responsible for ensuring that licence conditions were met in accordance with the legislation. See Infertility Treatment Act 
1995 (Vic), Pt 9. 
35 For example, the responsibility for the central register of donors/donor-conceived children will rest with the Registrar of Births, Deaths 
and Marriages. See Assisted Reproductive Treatment Act 2008 (Vic), Pt 6. 
36 Assisted Reproductive Treatment Act 2008 (Vic), s 100. 
 5 
 
 persons seeking to undergo treatment procedures must not be discriminated against on the basis of 
their sexual orientation, marital status or religion. 
Although the first guiding principle remains the same under the new legislative scheme, the 
remaining principles have been modified significantly.
37
 The third principle reflects the emphasis that the new 
legislation places on the right of donor-conceived children to access information about their genetic origins. 
This is a particularly welcome addition to the principles, given the growing recognition of this right generally.
38
 
Similarly, another welcome addition is the prohibition on discrimination against those seeking treatment.
39
 As 
discussed below, under the former statutory framework, there were significant inconsistencies in the way that 
the eligibility criteria were applied to those seeking treatments in Victoria.  
The Assisted Reproductive Treatment Act 2008 (Vic) also abandons the previous licensing system 
which was impliedly described as onerous by some commentators,
40
 and instead adopts a system of 
registration which enables individual medical practitioners and fertility clinics to apply to the VARTA for 
registration as an ART provider.
41
 This system of registration works alongside the national accreditation 
requirements set out by the FSA (discussed above). The 2008 legislation may, in time, facilitate a more positive 
response from ART providers in Victoria as it decreases the burden to comply with the complicated multi-
layered system that previously existed. 
The 2008 legislation also creates the Patient Review Panel, a new entity established to consider and 
review decisions relating to the provision of ART services.
42
 The Patient Review Panel is responsible for 
approving access to some ART procedures, such as those involving surrogacy arrangements or techniques 
resulting in posthumous conception.
43
 The Panel is also responsible for reviewing individual cases where 
prospective participants have a presumption against treatment imposed upon them on the basis of their 
previous criminal convictions, where participants have been refused access by ART providers, or where 
participants do not meet the statutory eligibility criteria. The significance of the Patient Review Panel is 
considered below. 
 
Regulating access to assisted reproductive technologies in Victoria 
Throughout Australia, limitations are placed on the accessibility of ART services. The availability of services will 
be dependent upon a number of factors, including:  
 the personal circumstances of those seeking treatments;  
 the financial costs of such treatments;  
 the geographical proximity of treatment services; and 
 the statutory or other legal limits (if any) imposed on those seeking access to treatments.  
While the factors in this list may be significant in the debate surrounding access to ART services generally, it is 
the last-mentioned aspect which is considered in the context of the Victorian legal regime. 
Access was originally limited to married or heterosexual de facto couples in Victoria, but this was 
challenged on the basis that it was inconsistent with a provision of the Sex Discrimination Act 1984 (Cth) which 
                                                          
37 The guiding principles under s 5(1) of the Infertility Treatment Act 1995 (Vic) required the application of the legislation to be informed by 
(a) the welfare and interests of any person born or to be born as a result of a treatment procedure are paramount; (b) human life should 
be preserved and protected; (c) the interests of the family should be considered; and (d) infertile couples should be assisted in fulfilling 
their desire to have children. The principles are listed in order of importance: Infertility Treatment Act 1995 (Vic), s 5(2). 
38 The Hon Dr Denis Vincent Napthine commented in relation to the addition of the principle, stating that “it is an important addition and 
reflects a real need, which is very important to children born as a result of donated gametes. It is important for their psychological health, 
for their access to genetic information and for their fundamental understanding of who they are”: Victoria, Legislative Assembly, 
Parliamentary Debates (9 October 2009) p 4017 (Denis Vincent Napthine). Furthermore, James Merlino MP argued that children “are not 
commodities. Children are not extensions of the rights and desires of adults; children exist in their own right. A child has the right to the 
truth – the truth to fundamental questions such as, “Where did I come from? Who are my biological mother and father … As an absolute 
minimum children who are born as the result of donor conception programs must be afforded the identical right and access to identifying 
information that we all agree is the right of adopted and surrogate children.” Victoria, Legislative Assembly, Parliamentary Debates (7 
October 2008) p 3770 (James Merlino, Minister for Sport, Recreation and Youth Affairs). 
39 This is also similarly acknowledged by Thorpe et al, n 4. 
40 For example, Baker described the ITA as generally unhelpful and intrusive: Baker HWG, “Problems with the Regulation of Assisted 
Reproductive Technology: A Clinician’s Perspective” (2002) 9 JLM 457 at 462. 
41 Assisted Reproductive Treatment Act 2008 (Vic), s 74. 
42 The Patient Review Panel consists of five members: Assisted Reproductive Treatment Act 2008 (Vic), s 83. Under s 85 of the legislation, 
its functions include: “(a) to consider applications for surrogacy arrangements; and (b) to consider whether there is a barrier to treatment 
if a presumption against treatment applies; and (c) to consider applications for posthumous use of gametes and embryos; and (d) to 
consider applications for treatment in circumstances in which a registered ART provider or doctor is concerned about the risk of abuse or 
neglect of a child that may be born as a result of treatment; and (e) to consider applications for treatment in circumstances in which the 
applicant does not meet the criteria for treatment; and (f) to consider applications for extended storage periods of gametes and embryos 
or removal of embryos from storage; and (g) any other functions given to the Panel by the Act or by the Minister.” 
43 See Thorpe et al, n 4 at 837-841. 
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prohibits discrimination on the grounds of marital status.
44
 Following the successful legal challenge to the 
marriage requirement, it has now been completely removed by the 2008 Act.
45
 
Although marital status is not of relevance for determining eligibility for ART services, there are still 
some requirements that must be met by participants before a woman (and where relevant, her partner) will 
be granted access to such services. The former legislation required participants to be infertile or at risk of 
passing on a genetic condition when conceiving naturally. Due to the fact that infertility had traditionally been 
interpreted as meaning medical infertility, this requirement had proven an obstacle to single and lesbian 
women seeking to access ART treatments. However, being single or having a female partner no longer 
constitutes infertility. The ITA had sought guidance on the interpretation of the term “unlikely to become 
pregnant” (contained within the former legislation).
46
 The ITA concluded that a woman must be medically 
infertile to gain access to treatment and therefore advised licensed clinics that women (including those who 
were not married or in a de facto relationship) could only be treated after a medical assessment confirming 
clinical infertility. 
The review of the Victorian legislation conducted by the VLRC noted that the eligibility criteria under 
the 1995 Act had been applied inconsistently to married women, women in heterosexual de facto 
relationships and women without legally recognised partners.
47
 It was for this reason that the report 
recommended a wider approach to the issue of eligibility in Victoria.
48
 The 2008 Act has widened the eligibility 
criteria by permitting access in cases where a doctor is satisfied, on reasonable grounds, that: 
 the woman is unlikely to become pregnant other than by a treatment procedure; or 
 the woman is unlikely to be able to carry a pregnancy or give birth to a child without a treatment 
procedure; or 
 the woman is at risk of transmitting a genetic abnormality or genetic disease as a result of a 
pregnancy conceived other than by a treatment procedure, including a genetic abnormality or genetic 
disease for which the woman’s partner is the carrier.
49
 
The wording of the new legislation is arguably broad enough to encompass the provision of services 
to single and lesbian women, even if those individuals are not medically infertile, as those women are “unlikely 
to become pregnant other than by a treatment procedure”. Furthermore, in cases where prospective 
participants do not meet the statutory eligibility criteria, the Patient Review Panel is able to make a decision as 
to whether a woman is able to access treatment procedures.
50
 In such circumstances, the Panel is required to 
make a decision in accordance with the guiding principles and whether the general or specific treatment is 
consistent with the best interests of a child born as a result of the procedure.
51
 In certain circumstances, a 
presumption against treatment will also apply to participants if certain criminal convictions are discovered 
after a criminal records check.
52
 In such cases, the Patient Review Panel is similarly able to review whether 
those seeking treatments should be provided with ART services.
53
 It is interesting to note the position in the 
United Kingdom where the Human Fertilisation and Embryology Authority (HFEA) has moved towards 
                                                          
44 In McBain v Victoria (2000) 99 FCR 116, the statutory marriage requirement was challenged on the grounds that a doctor could not 
comply with both the Commonwealth legislation and the State legislation when approached by a single woman seeking access to fertility 
treatment. The Federal Court of Australia held that the Victorian legislation is discriminatory and that the marriage requirement is 
inconsistent with the Commonwealth legislation under s 109 of the Constitution. 
45 The new legislation is based on many of the recommendations made by the Victorian Law Reform Commission and the Final Report 
concluded “that the marital status requirement is not only inconsistent with the principle of non-discrimination, but it also bears no 
relationship to the health and wellbeing of children, which must be the paramount concern of the law governing ART”: Victorian Law 
Reform Commission, n 3, p 67. 
46 Legal opinion of Gavan Griffith QC previously obtained from the ITA website. Contradicting advice was also given to the ITA by Peter 
Hanks QC who advised that Griffith’s interpretation reinforced the discriminatory nature of the legislation which was ruled unlawful in 
McBain – as women in a married or de facto relationship do not have to be clinically infertile to gain access to treatment procedures 
whereas a single woman does have to be clinically infertile to meet the access requirements. In response, Griffith confirmed his original 
interpretation of the term: Victorian Law Reform Commission, Assisted Reproduction & Adoption: Should the Current Eligibility Criteria in 
Victoria be Changed? Consultation Paper (2003) pp 26-27. 
47 VLRC, n 3, p 67. 
48 The VLRC, n 3, p 68, recommended that a “woman be eligible for treatment if she is unlikely to become pregnant and that her inability 
to become pregnant (or to carry a pregnancy or give birth to a child, or likelihood of transmitting a genetic abnormality or disease) be 
assessed on the basis of the circumstances in which she finds herself (whether single, married, in a same-sex relationship, psychologically 
averse to having sexual intercourse with a man, or otherwise)”. 
49 Assisted Reproductive Treatment Act 2008 (Vic), s 10(2). 
50 Assisted Reproductive Treatment Act 2008 (Vic), s 10(1)(b)(ii). 
51 Assisted Reproductive Treatment Act 2008 (Vic), s 15(3). 
52 Those seeking treatments are also required to undergo a criminal records check and where the woman or her partner (where relevant) 
have been convicted of particular sexual offences, or where there is a conviction in relation to a violent offence (or where a child 
protection check reveals that a child has been removed from the custody of the woman and/or her partner), a presumption against 
treatment will be imposed: Assisted Reproductive Treatment Act 2008 (Vic), s 14. 
53 Assisted Reproductive Treatment Act 2008 (Vic), s 15(1)(a). 
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imposing a presumption in favour of treatment which is rebutted where there is evidence to suggest 
significant harm or neglect to the child who will be born.
54
 As a result, prospective participants in the United 
Kingdom are no longer subjected to routine background checks. In Victoria, however, there has been a shift in 
the opposite direction under the new legislative scheme: the new provisions impose compulsory background 
checks upon those seeking treatment and in some circumstances a presumption against accessing treatment 
will be imposed.
55
 In such circumstances the participants would have to make an application to the Patient 
Review Panel in order to gain access to services.
56
 The scope of the Patient Review Panel’s decision-making in 
this context is outlined further below. 
The statutory eligibility criteria concerning access to ART services also impact significantly on the issue 
of accessibility more widely. When restrictions are imposed on the basis of medical need (eg medical infertility 
or avoiding transmission of genetic disease), such as those in Victoria, the result is that ART services are 
restricted in a narrow sense. For example, the imposition of narrow eligibility criteria restricts the availability 
of IVF for preimplantation tissue-typing; this technology is only available if the couple are at risk of passing on 
a genetic condition when conceiving naturally (or in cases where they are clinically infertile).
57
 To fall under the 
statutory eligibility criteria, it is necessary that the family’s primary intention is to use PGD techniques to 
detect a genetic condition in the embryo. If tissue-typing is undertaken, it is ancillary to this main purpose. 
An example that falls outside the scope of the narrow eligibility criteria is a couple seeking access to 
IVF for preimplantation tissue-typing, who are not at risk of passing on a genetic condition when conceiving 
naturally. Such a couple has no “medical need” (based on their reproductive capacity) to access services. In 
this context, the couple may have an existing child who is suffering from a condition that is not genetically 
inherited but has onset after birth. The desire to access IVF services is not based upon the need to prevent 
transmission of a genetic condition but is instead based on the wish to select an embryo for implantation that 
is of a matching tissue-type to the existing sick child. The medical need is for the benefit of treating the 
affected child. In this context, the couple would not be eligible for treatment in a jurisdiction (or an individual 
clinic) where narrow eligibility criteria are imposed. Fundamentally, such a family is prima facie ineligible for 
treatment under the Victorian legislation. 
In cases where prospective participants do not meet the statutory eligibility criteria, the Patient 
Review Panel is able to make a decision as to whether a woman is able to access treatment procedures.
58
 Thus, 
where a family does not meet the criteria contained within the reformed legislative scheme, they are able to 
apply to the Patient Review Panel to gain access to IVF for preimplantation tissue-typing.
59
 The Panel is 
required to make a decision in accordance with the guiding principles and to consider whether the general or 
specific treatment is consistent with the best interests of a child who may be born as a result of the 
procedure.
60
 For those families who do not fall within the scope of the statutory eligibility criteria, the option 
to apply to the Patient Review Panel is a welcome addition to the legislative scheme. However, as discussed 
below, in some cases this requirement may result in the need for families falling within this category to apply 
to multiple committees before being granted access to the technology. This hurdle creates an unnecessary 
inconsistency between the two categories of families who may seek access to such services in Victoria. 
 
The role of the Patient Review Panel and the Victorian Civil and Administrative Tribunal under the 
legislation 
It is evident that the Patient Review Panel and the Victorian Civil and Administrative Tribunal (VCAT) (in cases 
of review) have been entrusted with significant discretionary powers under the scope of the Victorian 
legislation. Thus, the Panel and VCAT are able to grant access to treatment in circumstances where 
participants would ordinarily be prevented from accessing services. Given the short timeframe which has 
passed since the legislation came into force, there is only limited authority to assist with interpreting the 
legislative provisions relevant to this specific aspect of the legislation. However, there are two VCAT decisions 
of particular relevance to the scope of these powers. 
In the decision of ABY, ABZ v Patient Review Panel (Health & Privacy) [2011] VCAT 1382 VCAT 
considered an application made by a couple who had sought IVF services from a registered ART provider. The 
female applicant, ABZ, was prevented from accessing IVF due to the fact that a ‘presumption against 
                                                          
54 Human Fertilisation and Embryology Authority, Tomorrow’s Children, Report of the Policy Review of Welfare of the Child Assessments in 
Licensed Assisted Conception Clinics (2005). 
55 Assisted Reproductive Treatment Act 2008 (Vic), ss 11, 14. 
56 Assisted Reproductive Treatment Act 2008 (Vic), s 15. For further discussion see Thorpe et al, n 4. 
57 It is submitted that this latter criterion is only likely to apply to a very small number of families seeking access to tissue-typing 
techniques, as the first (affected) child would have been conceived prior to the need for IVF. It is, however, possible to envisage a situation 
where a family has suffered diminished capacity to reproduce naturally following the birth of the affected child and in such circumstances 
they would fall within the statutory criteria. 
58 Assisted Reproductive Treatment Act 2008 (Vic), s 10(1)(b)(ii). 
59 Assisted Reproductive Treatment Act 2008 (Vic), ss 10(1)(b), 15(1)(b). 
60 Assisted Reproductive Treatment Act 2008 (Vic), s 15(3). 
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treatment’ was imposed on the basis of her partner’s prior criminal convictions.
61
 ABY’s criminal record check 
had revealed that he was convicted of a sexual offence falling within cl 1, Sch 1 of the Sentencing Act 1991 
(Vic). On this basis, ABY and ABZ made an application to the Patient Review Panel. As outlined above, the Panel 
is able to exercise its discretion to authorise the provision of treatment even in circumstances where a 
‘presumption against treatment’ exists.
62
 The Panel refused to exercise its discretion in the applicants’ favour. 
However, VCAT subsequently set aside the decision of the Patient Review Panel and ruled that there was no 
barrier to ABZ undergoing the treatment sought. VCAT made it clear that its functions when reviewing a 
decision of the Patient Review Panel are not appellate. They are instead focused on making the decision from 
‘the shoes of the original decision maker ... on the basis of the material before it’ (at [31]). VCAT concluded 
that the applicants in this case should not be prohibited from accessing treatment services.
63
  
Ultimately, VCAT’s ruling to set aside the decision of the Patient Review Panel was based on the fact 
that ABY’s prior criminal convictions were not necessarily contrary to the welfare or interests of any child who 
may be born following the provision of treatment services. VCAT observed that the majority of the Patient 
Review Panel had arrived at their decision on the basis that approval should not be granted for someone who 
is a registered sex offender (at [39]). It stated that the Victorian legislation confers a discretionary power upon 
the Patient Review Panel to consider applications such as this on a case-by-case basis and that the adoption of 
a rule which imposes a blanket prohibition on access to treatment for all registered sex offenders was ‘clearly 
wrong’ (at [39]). Thus, VCAT’s decision makes it clear that the discretionary power conferred upon the Patient 
Review Panel must be exercised on a case-specific basis and that the decision-making process must be guided 
by reference to the matters set out in s 15(3) of the Assisted Reproductive Treatment Act 2008 (Vic).
64
 It was 
further emphasised that the overarching principle in this context is based on how the circumstances in each 
case impact on the welfare of any child who may be born.
65
 
It is interesting to note that VCAT’s decision in ABY, ABZ made reference to a number of further 
factors which are relevant to applying the welfare principle in the context of the 2008 Act. It was stated that 
the principle does not require the Patient Review Panel or VCAT to conduct a general inquiry into participants’ 
parental capabilities. Instead, it requires an assessment of how the risks arising from previous criminal 
convictions would impact on a child who may be born following the provision of IVF services if access to 
treatment is granted (at [50]). VCAT distinguished the application of the ‘welfare principle’ in this context from 
the interpretation adopted in other legislative contexts involving children, such as cases concerning child 
protection and adoption.
66
 It also noted (at [51]) that ‘it is impossible to predict what will be in the best 
interests of a child who has yet to be conceived as each person is unique’. Furthermore, it stated (at [55]) that 
there is no ‘comparator’ to be drawn in the case of a child who is yet to be born as the decision to deny access 
to treatment would deny the potential child in question her or his ‘very existence’. It was acknowledged (at 
[55]) that a comparison between existence and non-existence is something that the courts have been unwilling 
to address.
67
 VCAT also refused to address the issue of how ABZ and ABY’s interests in having a child should be 
considered in the balance with the potential child’s interests. The interpretation of the welfare principle in this 
way could have a significant impact in cases where the parents are seeking access to IVF and preimplantation 
tissue-typing. This is because, ultimately, the child’s welfare cannot be assessed and therefore adversely 
                                                          
61 Assisted Reproductive Treatment Act 2008 (Vic), s 14(1). 
62 Assisted Reproductive Treatment Act 2008 (Vic), s 15(1). 
63 This decision was made subject to the condition that ABY attended 12 counselling sessions to address the implications of his previous 
convictions. Section 91(3) of the Assisted Reproductive Treatment Act 2008 (Vic) provides that the Patient Review Panel, and VCAT on 
review, may impose conditions on a decision which are considered to be ‘necessary and reasonable in the circumstances’. On this basis, 
VCAT set out detailed reasons as to why the condition was ‘necessary and reasonable’ in the circumstances. 
64 VCAT stated that s 15(3) imposes an obligation for the Patient Review Panel to have regard to the matters listed within that section and 
that the term ‘have regard to’ has been ‘constantly interpreted to mean that the decision-maker must take into account the matters to 
which regard is to be had [eg those factors listed within the Act] and each must be treated as a matter of significance in the decision 
making process (at *44+). Section 15(3) states: ‘In deciding the application for review, the Patient Review Panel must have regard to – (a) 
the guiding principles referred to in section 5; and (b) whether carrying out a treatment procedure, whether generally or of a specified 
kind, on the person – (i) is for a therapeutic goal; and (ii) is consistent with the best interests of a child who would be born as a result of 
the treatment procedure.’ 
65 VCAT noted (at *45+) that the use of the word ‘paramount’ in the context of the welfare principle means that it is interpreted to be an 
‘overriding’ principle.  
66 VCAT stated (at [53]-[54]) that the important difference between the welfare principle in the context of ART and the way it is applied in 
other contexts is that ‘in the other contexts the best interests of the child are evaluated by reference to a comparator. In family law it is in 
the context of a decision between parents (usually) as to who should have custody; in adoption cases it is between the couple before the 
court and others wishing to adopt; in cases involving the removal of a child from parental care it is between the status quo and care by the 
state. There is no appropriate comparator in the *context of ART+.’  
67 It should be noted that the courts have been unwilling to address this issue in the context of wrongful life claims. The decision in this 
instance was of a very different nature as it concerned the interests of a potential future person who would hopefully be born in a healthy 
state. It did not concern an assessment of whether an existing child, born with a disability due to alleged negligence, had been harmed for 
the purposes of establishing damages under the tort of negligence and thus, the only comparison that can be made in such circumstances 
is what would have happened if the harm had been avoided in some way. 
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affected, until that child is permitted to come into being. Thus, the reliance on welfare objections to deny 
access to treatment in this context may deny a potential saviour sibling her or his ‘very existence’. 
In the decision of JS and LS v Patient Review Panel (Health and Privacy) [2011] VCAT 856 VCAT was 
faced with an application from a couple seeking to utilise ARTs for the purpose of social sex selection. Section 
28 of the Assisted Reproductive Treatment Act 2008 (Vic) prohibits the use of ARTs for ‘producing or 
attempting to produce a child of a particular sex’ unless such practices are utilised for preventing the 
transmission of a genetic abnormality or disease, or where the Patient Review Panel has otherwise approved 
the use of such technologies for this purpose.
68
 JS and LS had lost a child of one sex and wanted to conceive 
another child of the same sex. The applicants had children of the opposite sex to the child who had died, but 
they did not want to conceive any further children of the same sex as their existing children. The applicants 
expressed their wish to complete their family by having a child of the desired sex and relied upon expert 
evidence to demonstrate how the loss of the child had impacted negatively on their emotional and 
psychological wellbeing. The couple sought to argue that by exercising discretion within the relevant provisions 
of the statutory framework, the Patient Review Panel (and subsequently VCAT) would allow the couple to 
‘move on’ and this course of action would assist in stabilising the couple’s emotional and psychological 
wellbeing. VCAT refused to exercise its discretion within the scope of s 28 of the Act. The primary reason for 
refusing to do so was again based on the interpretation of the welfare principle. VCAT observed that all of the 
supporting statements and expert evidence submitted in relation to the couple’s case had focused on the 
implications of having or not having a child of the same sex to the child who had previously died. It further 
observed that the evidence in the case had neglected to address the fact that the welfare and interests of any 
child who may be born following the provision of treatment services is the paramount consideration. Thus, the 
medical and supporting evidence was ‘concerned entirely with the interests of the parents’ (at [75]). 
Interestingly, and of most significance to the focus of this article, the VCAT decision concerning JS and 
LS referred to circumstances where IVF is utilised for the purpose of creating a tissue-matched child in order to 
draw a comparison between the two uses of ART. VCAT observed that there is some support (albeit, 
‘qualified’) for the use of ART in the latter context (at [30]). It observed that the creation of a saviour sibling is 
‘limited’ by the conditions imposed under the NHMRC Guidelines (as outlined below). However, it went on to 
comment that there ‘is a clear difference between protecting a child to be born from inheriting a serious 
genetic disorder, and bringing a life into being to provide tissue to save or prolong the life of a person who 
needs tissue from a compatible donor’ (at [33]). It did not elaborate fully on the ‘clear difference’ in this 
regard, but did observe that the ethical issues in the saviour sibling context require a weighing of the interests 
of the person who would receive the tissue and the interests of the saviour child. The distinction between 
‘protecting a child to be born from inheriting a serious genetic condition’ and selecting embryos on the basis of 
tissue-type, which was highlighted by VCAT, has been criticised heavily by other commentators with the 
observation that the PGD process does not provide a ‘benefit’.
69
 This is because the post-PGD embryo is in the 
same condition that it was prior to the biopsy process being undertaken and it is therefore difficult to argue 
that the particular child who is born has been ‘benefited’. Thus, the use of PGD in this context merely increases 
the probability of an unaffected embryo being implanted to achieve a pregnancy.
70
 
More concerning, however, is the lack of clear reasoning that was offered by VCAT as to why the 
saviour sibling issue is a relevant comparator for a case concerning sex selection for non-medical reasons. 
Social sex selection is prima facie prohibited by the Victorian legislation with the exception that the prohibition 
can be circumvented by the Patient Review Panel (or VCAT). In contrast, the provisions concerning the creation 
of saviour siblings are set out in the NHMRC Guidelines, which impose a number of factors that must be 
ascertained by an ethics committee prior to a family being granted access to IVF for this purpose. 
Fundamentally, this latter practice is not directly prohibited by the Assisted Reproductive Treatment Act 2008 
(Vic); it is merely regulated by the national ethical guidelines. This is a significant distinction that is not 
articulated clearly enough within VCAT’s decision in JS and LS. 
Furthermore, it is worth highlighting the inconsistency in the reasoning adopted by VCAT in the 
decision of JS and LS. The reasons put forward by VCAT were ultimately based on the fact that creating a child 
of one particular sex for non-medical reasons was not in accordance with the interests and welfare of the child 
to be born (or at least, that the parents did not take account of those interests). However, its reference to the 
use of IVF for the creation of a saviour sibling, which was deemed to be ‘supported’ to some extent, also fails 
to accord with this approach. Thus, relying on the assertion that JS and LS were concerned solely with their 
own motives is not significantly different from a case where the parents of an existing sick child rely on the 
desire to help cure their own sick child. In both cases, the reasons for having the child are not solely related to 
the welfare of the child who will be born or the desire to have a child for that child’s own worth. In both cases, 
to some extent the motives are instead related to the motives of someone other than the child who will be 
born (eg the parents’ desire for having a child of a particular sex, or the parents’ desire to help an existing child 
of their family and the existing sick child’s need for treatment). VCAT’s distinction between the two different 
                                                          
68 The practice is also prohibited at a national level under the NHMRC Guidelines, n 14 at [11]. 
69 See Sheldon S and Wilkinson S, “Hashmi and Whitaker: An Unjustifiable and Misguided Distinction?” (2004) 12(2) Medical Law Review 
137; Wilkinson S, Choosing Tomorrow’s Children (Oxford University Press, Oxford, 2010). 
70 Sheldon and Wilkinson, n 69 at 157-158 ; McLean S, Modern Dilemmas: Choosing Children (Capercaillie Books, Edinburgh, 2006) p 82. 
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uses of IVF for the selection of embryos must therefore be underpinned by some other undefined normative 
distinction, which deems the use of IVF as acceptable in one case but not another. 
 
Regulating preimplantation genetic diagnosis and preimplantation tissue-typing in Victoria 
The regulatory position concerning preimplantation tissue-typing has also been changed quite significantly 
following the reform process. Under the former statutory framework, the ITA oversaw the regulation of PGD 
techniques. Victoria’s approach to PGD regulation was one of the most comprehensive and prescriptive of all 
the Australian States and Territories.
71
 A three-tier system of regulation existed, requiring clinics to gain 
permission prior to undertaking PGD for certain purposes,
72
 including the detection and selection of embryos 
on the basis of tissue-type.
73
 It was initially expected that the VARTA would assume a similar responsibility for 
overseeing the regulation of PGD, as the new statutory body had updated the ITA’s guidance concerning PGD 
and pre-implantation tissue-typing.
74
 However, the statutory body has confirmed that it will not play a role in 
the future regulation of PGD techniques.
75
 Thus, regulation is a matter to be determined by individual clinics. 
This significant change seems to accord with the general spirit of the new statutory framework, which has 
attempted to adopt a “light touch” compared to the former framework. This change in policy leaves the 
regulatory position in Victoria concerning PGD similar to the position in New South Wales.
76
 
The implication of this change in policy is that the regulation of PGD and preimplantation tissue-
typing will no longer be determined by the Victorian regulatory body, but will instead be subject to the usual 
regulatory provisions impacting on fertility clinics (including the NHMRC Guidelines). It is no longer necessary 
to gain case-by-case approval from the statutory body, due to the fact that the policies developed by the 
former ITA and updated by the VARTA concerning PGD and preimplantation tissue-typing are no longer in 
force.
77
 In some respects, this change is a move in the right direction, given that the former tissue-typing policy 
explicitly excluded access to the technology in cases where the statutory eligibility criteria were not met. 
However, complete removal of the policy also raises a number of concerns, some of which are outlined below. 
As established above, all ART clinics in Australia are required to adhere to national guidelines relevant 
to ART practices. Therefore, PGD practices in Victoria will now be influenced solely by the NHMRC Guidelines 
as there is no longer a specific State policy. According to the NHMRC Guidelines, ART providers must carefully 
evaluate any use of PGD and in the context of preimplantation tissue-typing, the technology should only be 
provided where: 
 the intended recipient of tissue is a sibling, and in such instance, the clinic must seek advice from a 
clinical ethics committee (or where relevant, a State or Territory regulatory agency); and 
 the relevant committee or agency must ascertain that: 
o preimplantation tissue-typing does not adversely affect the welfare and interests of the child 
who may be born; 
o the medical condition of the sibling must be life-threatening; 
o there are no other means available for treating the condition; and 
o the wish of the parents is to have another child as an addition to their family and not merely 
as a source of tissue.
78
 
In addition to these factors, there are a number of general requirements stipulated under the national 
guidelines relating to the provision of information and counselling which must also be complied with.
79
 
However, in relation to information-giving, the NHMRC Guidelines are specific to the genetic implications of 
                                                          
71 See Petersen, n 26. 
72 The three-tier system permitted the use of preimplantation genetic diagnosis under three categories: (i) cases for which no permission 
or notification is required to undertake preimplantation genetic diagnosis – this only applied to established uses as outlined in the 
preimplantation genetic diagnosis policy; (ii) cases that are not established did not require permission to be obtained, but the use of 
preimplantation genetic diagnosis was reportable to the ITA; and (iii) in cases where the use of the technology is novel, approval had to be 
obtained from the ITA (and clinics were also required to notify the Authority of such uses): Infertility Treatment Authority, Genetic Testing 
and the Requirements of the Infertility Treatment Act 1995: Policy in Relation to the Use of Pre-implantation Genetic Diagnosis (PGD) 
(2008) pp 5-6. 
73 ITA, Tissue Typing in Conjunction with Preimplantation Genetic Diagnosis: Interim Guidelines (2007) p 1. 
74 Victorian Assisted Reproductive Treatment Authority, Conditions for Use of Tissue Typing in Conjunction with Preimplantation Genetic 
Diagnosis (PGD) (2010). 
75 This information was provided by Tracey Petrillo, Senior Policy and Education Officer, Victorian Assisted Reproductive Treatment 
Authority: email communication (February 2011). 
76 See Smith M, “Reviewing Regulation of Assisted Reproductive Technology in New South Wales: The Assisted Reproductive Technology 
Act 2007 (NSW)” (2008) 16 JLM 120. 
77 Confirmed by Tracey Petrillo, Senior Policy and Education Officer, Victorian Assisted Reproductive Treatment Authority: email 
communication (February 2011). 
78 NHMRC Guidelines, n 14, pp 55-56. 
79 NHMRC Guidelines, n 14, pp 55-56. 
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PGD and fail to address the implications of using the technology for the purpose of creating a tissue-matched 
child.
80
 In the latter context, the level of information that should be provided to participants by ART clinics is 
left unclear. Similarly, the counselling process is also inadequately addressed under the NHMRC Guidelines as 
there is little detail provided in relation to the level of counselling that should be provided to families utilising 
tissue-typing techniques. These factors were addressed in greater detail under the State-specific policy that 
was created by the ITA (as updated by the VARTA).
81
 It is unfortunate that these factors will be left in a state of 
uncertainty following the removal of the policy. It should be noted, however, that counselling for IVF 
procedures in Victoria is compulsory under the statutory scheme and this would hopefully enable many of the 
specific issues associated with preimplantation tissue-typing to be addressed. 
Although there is no longer a requirement for clinics to seek case-by-case approval from the VARTA 
for the provision of tissue-typing techniques in Victoria, there is a requirement under the NHMRC Guidelines 
to refer the request to an institutional ethics committee. This requirement is underpinned by the need to 
consider the welfare of any potential child who may be born. However, as outlined above, a family that is not 
eligible for treatment under the statutory scheme in Victoria would need to apply to the Patient Review Panel 
to be granted access to treatment. The Patient Review Panel (or, where relevant, VCAT) is required to make an 
assessment in each case on the basis of the circumstances of the case before it. At both stages of this process, 
the Patient Review Panel and the ethics committee are required to consider, among other things, the welfare 
of any child who will be born following the provision of treatment services. There appears to be no 
consideration given to the fact that some families seeking to create a saviour sibling, who fall outside of the 
statutory eligibility criteria, will be subjected to two levels of scrutiny when seeking access to the technology. 
The legislature had the option to include this specific exception within the statutory eligibility criteria when 
drafting the legislation, but failed to do so. 
Furthermore, as outlined above, a welfare assessment may be particularly difficult to make in the 
context of a case concerning preimplantation tissue-typing. In this specific context, the literature has outlined 
a range of potential risks that a child may be subjected to if he or she is created as a saviour sibling.
82
 However, 
such risks are merely speculative at the pre-conception stage. The difficulty is that the NHMRC Guidelines lack 
specificity as to how a child born in this way may have her or his welfare adversely affected. For this reason, 
there is no clear basis upon which an ethics committee (or other relevant body) is justified in preventing a 
clinic from providing IVF and PGD services for this specific purpose. The previous State-level guidelines 
elaborated on at least some of the requirements that are relevant to assessing the welfare of the child. For 
example, it was necessary to establish:  
 that specific consideration be given to the first guiding principle of the legislation (that the interests of 
the person to be born are of paramount concern); and 
 that the resulting child born as a result of the procedure should only provide cord blood or bone 
marrow and that the harvesting of “hard” or non-regenerative organs is not acceptable.
83
 
In addition to these factors, the ethics committee of the institution where the procedure would be 
carried out was also required to consider a number of further issues, including: 
 the motivation and level of understanding of the parents in seeking to have an additional child; 
 the issues that may arise where the birth of a child does not resolve the genetic condition for the 
existing sibling; and 
 the status of the child within the family and the relationships, which grow, with the growth of all 
children within the family.
84
 
Given that the State-level guidance had been in force for some time before it was revoked, it is 
possible that in the future, ethics committees of ART clinics in Victoria may make reference to these factors. In 
the absence of such considerations, given the lack of detail in the national guidelines, there is the potential 
that different ethics committees will adopt different reasoning to justify why some families should be 
prevented from accessing the technology. 
For the specific issue of preimplantation tissue-typing, the NHMRC Guidelines are arguably 
inadequate in addressing the full range of factors that are relevant to the welfare assessment. Despite this 
conclusion, however, the adequacy of the guidelines should be considered in context. The original NHMRC 
Guidelines released in 1996 did not address a number of the more controversial aspects of ARTs (including 
PGD) as these issues were considered to be beyond the remit of the Australian Health Ethics Committee 
(AHEC). These issues were left to each State and Territory to decide upon and it was the failure of the majority 
of Australian jurisdictions to address the more controversial issues which led the AHEC to issue a more 
                                                          
80 This can be compared to the position in the United Kingdom, where the implications of using preimplantation genetic diagnosis for 
tissue-typing are addressed in considerable detail: Human Fertilisation and Embryology Authority, Code of Practice (8th ed, 2009) at [10].  
81 VARTA, n 74. 
82 See Bellamy S, “Lives to Save Lives – The Ethics of Tissue Typing” (2005) 8 Human Fertility 5. 
83 VARTA, n 74, pp 2-3. 
84 VARTA, n 74, pp 2-3. 
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comprehensive set of guidelines in 2004
85
 (which were again updated in 2007 to incorporate changes in 
Commonwealth legislation relating to human embryo research and cloning). Therefore, the inadequacy of the 
current guidelines is not necessarily a reflection of the way that the AHEC developed policy on this matter. The 
national guidelines were aimed at providing a minimum standard of ethical practice in the context of ARTs. It 
was intended that each State and Territory provide further detail to supplement the guidelines. It is therefore 
interesting to note that Victoria has reversed its approach concerning this issue, as it was the only Australian 
jurisdiction that did, in fact, address it beyond the scope of the NHMRC Guidelines. 
 
CONCLUSION 
The changes to the Victorian regulatory framework concerning ART are some of the most significant since 
State legislation on the issue was first enacted. The statutory scheme has moved towards a light touch. This is 
a growing trend within the Australian statutory jurisdictions, with a number of States adopting a registration-
based regulatory approach (compared to the former licence-based approach).
86
 One explanation for this shift 
in direction could be the recognition that the previous, multi-layered approach to regulation was complicated 
and burdensome. Thus, as outlined above, there is a need to comply with a number of different sets of 
national guidelines as well as the statutory system in place in Victoria.  
A more radical change in policy is that concerning PGD and preimplantation tissue-typing. The change 
in policy concerning PGD has not resulted directly from the changes to the legislative scheme, but has occurred 
as a result of the VARTA’s decision to hand over the regulatory issues associated with the technology to the 
profession. This is not necessarily a radical step when considered in the context of other State approaches, 
many of which have failed to regulate PGD in any sense. However, this is a significant shift in policy when 
considered in the context of the history of ART and PGD regulation in Victoria.  
It was established that the MHMRC Guidelines with respect to PGD and tissue-typing techniques will 
continue to apply in Victoria following the abolition of the State-specific policies. Although the changes to the 
statutory eligibility criteria open up the possibility that those families who do not fall within the criteria may be 
able to gain access to preimplantation tissue-typing, there is still a requirement that such families seek 
approval from the Patient Review Panel prior to being considered for IVF treatment. This means that those 
families who do not meet the statutory eligibility criteria (eg families who have a sick child with an acquired 
condition) will have to gain permission from the Patient Review Panel prior to having their case considered by 
an institutional ethics committee. Both the Patient Review Panel and the ethics committee are obliged to 
consider the respective applications in accordance with the guiding principles of the legislation (among the 
other considerations mentioned), and place the welfare of the child to be born as paramount. As highlighted 
by the recent decisions of the Victorian Civil and Administrative Tribunal, welfare assessments in this specific 
context may prove particularly difficult to make.  
The effect of the change in Victorian regulatory policy concerning preimplantation tissue-typing is 
that it amounts to a double assessment of the decision of some families to access IVF for this purpose. 
Essentially, at both stages of the assessment, the Patient Review Panel and the institutional ethics committee 
are required to consider the same matters: the family circumstances and how these impact on the welfare and 
interests of any child who may be born following the procedure. This double assessment is an unjustified 
hurdle for some families, given that other families who are at risk of transmitting a genetic condition via 
natural conception are not subject to the same requirements. Arguably, both families have the same 
motivation and intention in using the technology. For this reason, there is a need for Victoria to reconsider its 
approach in relation to this specific issue, so that all families who seek to rely on IVF and preimplantation 
tissue-typing for such compelling reasons are able to do so without having to jump through unjustifiable 
hurdles. 
 
                                                          
85 Szoke, Neame and Johnson, n 25. 
86 This position has also been adopted in New South Wales (see Smith, n 76) and South Australia.  
